Market Reach Clinisys serves over 4,000 labs across 39 countries with a broad sector footprint including healthcare, public health, environmental sciences, food & beverage, and life sciences, presenting cross-sell opportunities into physician offices, reference labs, and veterinary labs.

Global Leadership With approximately 24% global market share in lab informatics (Signify Research, 2025) and a growing footprint in Europe and the US, there is a strong value proposition for enterprise-grade integrations and expansion into biotech and pharma segments.

AI & Innovation Recent launches like CLS CARE and CLS v2025.2, plus AI-powered support through CLS CARE, indicate a pathway for selling advanced analytics, automated reporting, and governance features to labs seeking efficiency and quality assurance.

Strategic Partnerships New partnerships and integrations with hospitals, regional health organizations, distributors in Latin America, and Ireland’s Socrates Healthcare Ltd demonstrate a channel-driven route to accelerate new lab onboarding and geographic expansion.

Growth Readiness Funding is reflected in ongoing product expansions and industry event participation (Bio-IT World Conference & Expo), suggesting opportunities to position Clinisys as a scalable, future-proof informatics platform for labs planning modernization and remote testing capabilities.